Role of the CMC Regulatory Strategist in Due Diligence

Posted 01 July 2009 | By

A pharmaceutical or biologic due diligence exercise is a matchmaking process between two companies. It is undertaken to explore a potential deal driven by one company's need for another's medicinal product, medical device or technology, or in some cases, the other company in its entirety.


Regulatory Focus newsletters

All the biggest regulatory news and happenings.